The regulatory effect of 5-aza-2,-deoxycytidine in cervical cancer cells
10.3969/j.issn.1006-5725.2016.18.015
- VernacularTitle:5－氮杂－2＇－脱氧胞苷对宫颈癌细胞的基因表达调控
- Author:
Guandi CHEN
;
Geying FAN
;
Keli YOU
;
Deying QIAN
;
Jinmin CEN
;
Yanhong SHU
;
Zhigang LI
- Publication Type:Journal Article
- Keywords:
5-Aza-dC;
Cervical cancer cells;
DNA methylation;
p16;
MGMT
- From:
The Journal of Practical Medicine
2016;32(18):2995-2999
- CountryChina
- Language:Chinese
-
Abstract:
Objective To discuss the regulatory effect of 5-aza-2 ,-deoxycytidine on P16 and MGMT in cervical cancer cells. Methods After four kinds of cervical cancer cells (HeLa, SiHa, C33A and CaSki) were treated with 5-Aza-dC , MSP was used to detect the methylation variation of P16 and MGMT , and fluorogenic quantitative PCR and Western blot were employed for determination of P16 and MGMT expression. MTT and Annexin V-FITC/PI double staining were adopted for detection of cell proliferation and apoptosis. Results Both P16 and MGMT exhibited methylation in four kinds of cervical cancer cells , and after treatment with 5-Aza-dC ,their methylation levels were reversed. 5-Aza-dC was able to inhibit p16 and MGMT expression in the cervical cancer cells, and can also suppress cell proliferation and promote apoptosis. Conclusions Although methylation of P16 and MGMT are present in cervical cancer cells, their expression level was still high. Therefore, regulation of P16 and MGMT expression may be affected by other factors. 5-Aza-dC can suppress the growth of cervical cancer cells. Although 5-Aza-dC reverse the methylation levels of P16 and MGMT, it inhibits their gene expression. More experiments are needed to verify the hidden reasons and mechanisms.
